https://www.selleckchem.com/pr....oducts/etomoxir-na-s
anning techniques allow for improved normal tissue sparing compared with currently established dose constraints without compromising disease control. These improvements may lead to reduced toxicity in a patient population expected to have favorable long-term outcomes. Stricter constraints can be easily achieved and should be used in conjunction with other evolving efforts to mitigate toxicity.Developments in genomics are profoundly influencing medical practice. With increasing use of genetic and genomic testing across every asp
Beğen
Yorum Yap
Paylaş
